Atlas Trials

Lenalidomide for Patients With Myelofibrosis (MF)

Clinical trial NCT00352794 · COMPLETED

Trial details

NCT number
NCT00352794
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Myelofibrosis
Start date
2006-07-07
Primary completion
2018-03-08
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.